Skip Navigation
Wilmer Eye Institute
Print This Page
Share this page: More

Dr. Hendrik Scholl Shares Thoughts on Gene Therapy for Retinal Diseases


Dr. Hendrik Scholl

Dr. Hendrik Scholl, a professor of ophthalmology in Wilmer's retina division, contributed an editorial on a recent study on the effectiveness of gene therapy to treat progressive retinal diseases. The results of the study, whick took place at Oxford Eye Hospital in the U.K., were published by Lancet on January 16 and indicated that a group of patients with choroideremia, an inherited retinal disease which leads to blindness by middle age, showed some improvement in vision after receiving a single injection of gene therapy. Dr. Scholl was chosen by Lancet to comment on the study given his expertise in inherited retinal and macular degenerations.

The full study is also available on Science Direct, with Dr. Scholl's comment also available.

Dr. Scholl was interviewed on Canada's CTV network's morning news program about the positive implications of the study.



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.